-+ 0.00%
-+ 0.00%
-+ 0.00%

Aura Biosciences repurchases Matrix stake for USD 39.04 million at USD 5.64/share

PUBT·05/04/2026 20:33:46
Listen to the news
Aura Biosciences repurchases Matrix stake for USD 39.04 million at USD 5.64/share
  • Aura Biosciences entered a privately negotiated deal to repurchase up to 6,922,870 common shares from Matrix Capital Management Master Fund.
  • Buyback price set at USD 5.64 per share, matching underwriters’ purchase price in Aura’s separately announced equity offering.
  • Repurchase funded from net equity offering proceeds above USD 200 million; closing expected no earlier than two business days after equity offering closes.
  • Matrix held about 10.8% of outstanding common stock as of April 15, 2026, before equity offering or buyback.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-204049), on May 04, 2026, and is solely responsible for the information contained therein.